Latest: The tech used by cell and gene therapy scientists
Latest: Beckman Coulter and Fujirebio expand partnership to develop patient-friendly,...
Latest: Optimize monoclonal antibody development with icIEF-UV/MS
Latest: SelectScience introduces its new merch
Latest: SelectScience Analytical Science Summit 2024 – Taking place today!
Latest: 7 reasons to register for the Analytical Summit 2024
Latest: AI microscopy breathes new life into asthma research
The tech used by cell and gene therapy scientists
Tech drives change and learning in cell and gene therapy
Cologuard Plus test outshines fecal immunochemical test in pivotal BLUE-C study
Naveris awarded ADLT status by CMS for the NavDx test
Driving drug discovery with enhanced cell culture capabilities
7 innovations in gene editing technology
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
High-throughput bacterial isolation and culture using dragonfly discovery
Library preparation kit – Lys-C data sheet
Platinum instrument and Sequencing Kit V2 data sheet
Platinum analysis software data sheet
How to Buy Cell Counting Equipment
Microplate Readers
How to Buy Microscopy Equipment
How to Buy Water Purification Technology
How to Buy Clinical Laboratory Automation Technology
Biophysical Characterization Technology
AACR 2024
05 Apr 24 - 10 Apr 24
The Microbiology Society...
08 Apr 24 - 11 Apr 24
GFSI
BOOM Summit 2024
10 Apr 24 - 11 Apr 24
Analytica: World's Leading...
09 Apr 24 - 12 Apr 24
Advertisement
Recombinant Rubella (strain F-Therien) virus-like particles consisting of spike glycoprotein E1, spike glycoprotein E2 and Capsid protein, produced in mammalian HEK293 cells. Read more...
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-tran... Read more...
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-tran... Read more...
The Native Antigen Company offers a selection of complementary easy-to-use antibody conjugation formats, with a wide range of labels suitable for use in most applications. On request we can also undertake custom conjugation of proteins an... Read more...
With decades of experience in the field of native antigen and recombinant protein production, and assay development, The Native Antigen Company is able to undertake a wide range of custom projects on your behalf. Read more...
SARS-CoV-2 Nucleoprotein is a recombinant antigen manufactured in E. coli cells to high purity for use in vaccine research and immunoassay development. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pand... Read more...
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell pl... Read more...
SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 201... Read more...
Human Coronavirus 229E Nucleoprotein is a recombinant protein containing 359 amino acids derived from the nucleocapsid sequence, with a C-terminal 6xHis tag. It is manufactured in E. coli with greater than 95% purity. Read more...
Human Coronavirus NL63 Nucleoprotein is a recombinant protein containing the nucleocapsid C-terminal region (130 amino acids), cloned and expressed in E. coli, and purified by affinity chromatography (nickel column) with greater than 95% ... Read more...